2 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Not yet recruiting 1, Recruiting 1, Terminated 1 |
Follow Disease Susceptibility: new trials by email Literature Review of Disease Susceptibility trials Research Report on Disease Susceptibility
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans Exendin 9-39, Saline - Genetic Predisposition, Type2diabetes | Phase 2 | Not yet recruiting | Mayo Clinic | 80 | 2026-10-01 | 2026-01-30 |
| Microbiome and Association With Implant Infections Cephalexin - Breast Cancer, Breast Cancer Female | Phase 2 | Recruiting | University of California, San Francisco | 200 | 2021-09-28 | 2026-03-18 |
| Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria Lisinopril, Placebo Oral Tablet - HIV/AIDS, Albuminuria | Phase 2 | Terminated | Vanderbilt University Medical Center | 66 | 2021-04-01 | 2025-06-26 |
| Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus Daptomycin, PMX-30063-investigational drug - Acute Bacterial Skin and Skin-structure Infection(ABSSSI) Due to Staphylococcus Aureus (MSSA), (Susceptible or Methicillin Resistant) | Phase 2 | Completed | PolyMedix, Inc. | 215 | 2010-10-01 | 2012-05-17 |
| Clopidogrel Pharmacogenomics Project clopidogrel 75 mg, Clopidogrel 150 mg - Disease Susceptibility | Phase 2 | Completed | University of North Carolina, Chapel Hill | 50 | 2010-03-01 | 2017-12-12 |
Genetic Predisposition to Disease (3) · Acquired Immunodeficiency Syndrome (1) · Albuminuria (1) · Breast Neoplasms (1) · Kidney Diseases (1) · Staphylococcal Infections (1)
Disease Attributes (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Infections (2) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Blood-Borne Infections (1) · Breast Diseases (1) · Communicable Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Gram-Positive Bacterial Infections (1) · HIV Infections (1)
Cephalexin (1) · Clopidogrel (1) · Daptomycin (1) · Lisinopril (1) · Sodium Chloride (1) · exendin (9-39) (1)
Mayo Clinic (1) · PolyMedix, Inc. (1) · University of California, San Francisco (1) · University of North Carolina, Chapel Hill (1) · Vanderbilt University Medical Center (1)
United States (3) · Canada (1) · Nigeria (1) · Russia (1) · Ukraine (1)
Adrian Vella, MD (1) · C. William Wester, MD, MPH (1) · Joseph Rossi, MD (1) · Merisa Piper, MD (1) · Muktar H. Aliyu, MD, DrPH (1)
U01DK112271 (1)